Abstract Submission Deadline: November 24, 2026
Pre-Early Bird Registration Ends: November 26, 2026
Cancer R&D 2027 - United Scientific Group Official Logo
United Scientific Group (USG)

12th International Conference on Cancer Research & Drug Development

October 13–15, 2027 | Houston, TX
Venue: Sheraton North Houston at George Bush Intercontinental, Texas
Submit Abstract Register Now
Keynote Lectures
Keynote Lectures

World-class Oncology Faculty

1/6
Lifetime Award
Lifetime Award

Excellence in Cancer Research

2/6
Translational Science
Translational Science

Clinical & Lab Breakthroughs

3/6
Drug Development
Drug Development

Targeted Therapies & Biomarkers

4/6
Precision Medicine
Precision Medicine

Tumor Biology & Diagnostics

5/6
Collaborative Sessions
Collaborative Sessions

Global Scientific Exchange

6/6
// CONGRESS OVERVIEW

About Cancer R&D 2027

ORGANIZED BY UNITED SCIENTIFIC GROUP (NON-PROFIT)
Join the Global Leaders in Cancer Research at Cancer R&D 2027!

Welcome to the 12th International Conference on Cancer Research and Development (Cancer R&D 2027), a prestigious three-day congress hosted by United Scientific Group (USG), a distinguished non-profit organization committed to the progression of cancer research.

Scheduled from October 13–15, 2027 in Houston, TX, this premier gathering unites global investigators, clinicians, and biotech innovators to cultivate knowledge, present unpublished breakthroughs, and foster cross-disciplinary collaborations that translate laboratory discoveries into life-saving therapies.

Why Attend Cancer R&D 2027?

  • •Gain insights from internationally recognized cancer researchers and scientific leaders.
  • •Discover emerging research and innovative approaches shaping the future of cancer treatment.
  • •Build meaningful connections with experts, potential collaborators, and industry professionals from around the world.
Read More
Lifetime Achievement Award Ceremony
Recognizing a Distinguished Contribution to Cancer Research
Lifetime Achievement Award Presentation to Prof. Georg F. Weber

One of the memorable moments of Cancer R&D-2026 was the presentation of the Lifetime Achievement Award to Prof. Georg F. Weber, University of Cincinnati, Ohio, USA, in recognition of his distinguished contributions to cancer research, particularly his work on metastasis, integrin-CD44 signaling, and cancer-associated stress responses.

The award was presented by Prof. Kenneth Blum, President of United Scientific Group, together with Dr. Raghu Kalluri, the 2025 recipient of the Cancer R&D Lifetime Achievement Award.

DISTINGUISHED SCIENTIFIC FACULTY Cancer R&D 2027

Plenary & Keynote Speakers

Prof. Raghu Kalluri

Prof. Raghu Kalluri, MD, PhD

The University of Texas MD Anderson Cancer Center, TX

Prof. Mark D. Pegram

Prof. Mark D. Pegram, MD

Stanford University School of Medicine, CA

Dr. Andres McAllister

Dr. Andres McAllister, MD, PhD

Chief Medical Officer, BioInvent International AB, Sweden

Dr. Ying-Chih Chang

Dr. Ying-Chih Chang, PhD

Founder & CEO, Acrocyte Therapeutics Inc.,Taiwan

Prof. Georg F. Weber

Prof. Georg F. Weber, PhD

University of Cincinnati, OH

Prof. Keith T. Wilson

Prof. Keith T. Wilson, MD

Vanderbilt University Medical Center, TX

View More Speakers
// CALL FOR ABSTRACTS

Scientific Sessions

Cancer R&D-2027 brings together diverse areas of oncology research, therapeutic innovation, and drug development through eight major scientific tracks. The program is designed to encourage interdisciplinary exchange and highlight advances spanning fundamental cancer biology to clinical applications. Further details on individual presentations, session schedules, and speakers will be announced as the program develops.

Track 01

Cancer Biology, Genetics & Molecular Oncology

Track 02

Tumor Microenvironment, Progression & Metastasis

Track 03

Cancer Immunology, Immunotherapy & Cellular Therapeutics

Track 04

Precision Oncology, Targeted Therapies & Drug Discovery

Track 05

Cancer Diagnostics, Biomarkers, AI & Computational Oncology

Track 06

Emerging Therapeutics, Drug Development & Therapeutic Resistance

Track 07

Translational Oncology, Clinical Research & Organ-Specific Cancers

Track 08

Cancer Prevention, Early Detection & Innovative Technologies

Call for Abstracts Now Open Submit your research under any of the 8 scientific tracks above.
Submit Abstract
// OUR FEATURES

Our Features — Cancer R&D-2027

Excellence in Oncology • Community & Discovery
01

Network

Having a great networking is inexpensive. It opens the doors for you and offers you a land of opportunity that might help you to spread your wings. Network face to face building a rapport with someone leading a solid connection in the research you are sailing. Cancer R&D 2027 brings that platform helping to create a foundational trust.

CONNECT & ENGAGE
02

Past Programs

The previous 10 editions of the Cancer R&D conference were a great success and has brought together more than 1050+ researchers from leading institutes and organizations.

PROVEN HERITAGE
03

Collaborate

Great achievements and improvements invariably involve the cooperation of many minds. Collaboration allows us to more than we are capable of knowing by ourselves and helps us to think out of box. At Cancer R&D 2027 you will find those minds to collaborate and achieve your goals.

TEAM SCIENCE
04

Showcase

Research is to see what everybody else has seen but think what nobody else has thought. We at Cancer R&D 2027 created a platform to share that thought. Join us today to present the work to your peers in the world of Cancer Research.

SHARE DISCOVERY
// CANCER R&D 2027

Registration

Pre Early Bird Registration Ends: November 26, 2026
University / Institute
$699 USD

Academic

  • Welcome Coffee
  • Conference Material
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register Now
Biotech & Pharma Recommended
$799 USD

Industry

  • Welcome Coffee
  • Conference Material
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register Now
Attendee / Listener
$749 USD

Delegate

  • Welcome Coffee
  • Conference Material
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register Now
// 12 YEARS OF ONCOLOGY EXCELLENCE (2016 — 2027)

Interactive Congress Heritage Archive Scrubber

Click any edition below to inspect historical milestones from 11 previous conferences uniting 1,050+ leading cancer researchers.

CRD-2027 12th Edition (Houston)

Upcoming Flagship Congress: October 13–15, 2027 at Sheraton North Houston at George Bush Intercontinental, Texas.

// VERIFIED PEER ENDORSEMENTS

Voices from Past Cancer R&D Editions

// SOCIAL PULSE

Latest from Our LinkedIn Community

Stay informed with real-time updates, speaker spotlights, scientific discussions, and conference announcements directly from our official feed.

Follow Us
// GET IN TOUCH

Contact Us

USG United Scientific Group Secretariat
CONFERENCE SECRETARIAT

Cancer R&D 2027

Have questions regarding scientific sessions, registration, abstract review, or exhibiting opportunities? Our secretariat is available to assist you.

Official Email crd@uniscigroup.org
contact@unitedscientificgroup.org
Phone / Fax +1-469-854-2280 / 81
Toll-Free (USA/Canada): +1-844-396-7078
USG Headquarters United Scientific Group (A non-profit organization) 8105 Rasor Blvd - Suite #112, Plano, TX 75024, USA
Response Time: Typically within 24 business hours
// DISPATCH INQUIRY

Send us a Message

Fill out the form below and the conference coordinators will reply promptly.